(Q38110730)

29 August 2017

title

Immunotherapy preparation guidelines, rules, and regulation (English)

1 reference

29 August 2017

1 reference

Robert E Esch

1

1 reference

29 August 2017

Greg A Plunkett

series ordinal

2

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Current Allergy and Asthma Reports

29 August 2017

published in

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

406-413

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-013-0358-8

29 August 2017

exact match

0 references

cites work

Allergen immunotherapy: a practice parameter third update.

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Laboratory methods for allergen extract analysis and quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Evaluation of allergen vaccine potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Manufacturing and standardizing fungal allergen products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Regulatory aspects of allergen vaccines in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Responses to ragweed-pollen nasal challenge before and after immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Immunologic response to administration of standardized dog allergen extract at differing doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Survey on immunotherapy practice patterns: dose, dose adjustments, and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Stability of allergen extracts used in skin testing and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Cross-reactivity of plant and animal allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

Allergen compatibilities in extract mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

The burden of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0358-8

A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults

21 January 2018

1 reference

12 December 2020

Component-resolved diagnosis-assisted prescription of allergen-specific immunotherapy: a practical guide.

1 reference

12 December 2020

Pain and dermal reaction caused by injected glycerin in immunotherapy solutions

1 reference

12 December 2020

Comparison of allergen immunotherapy practice patterns in the United States and Europe

1 reference

12 December 2020

Effect of mixing allergenic extracts containing Helminthosporium, D. farinae, and cockroach with perennial ryegrass.

1 reference

12 December 2020

Role of proteases on the stability of allergenic extracts

1 reference

12 December 2020

A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects

1 reference

12 December 2020

Allergen immunotherapy: what can and cannot be mixed?

1 reference

12 December 2020

The potential impact of USP 797 and what the JCAAI is doing about it

1 reference

12 December 2020

Immunotherapy for cat asthma

1 reference

12 December 2020

Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units

1 reference

12 December 2020

Immunotherapy decreases skin sensitivity to cat extract

1 reference

12 December 2020

Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy

1 reference

12 December 2020

Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009

1 reference

12 December 2020

Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract

1 reference

12 December 2020

10.1007/S11882-013-0358-8

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1046001570

0 references

1 reference